A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.

Toxicol Sci

Ecotoxicology and Wildlife Health Division, Environment and Climate Change Canada, Ottawa, Ontario K1S 5B6, Canada.

Published: November 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The adverse outcome pathway (AOP) framework provides a practical means for organizing scientific knowledge that can be used to infer cause-effect relationships between stressor events and toxicity outcomes in intact organisms. It has reached wide acceptance as a tool to aid chemical safety assessment and regulatory toxicology by supporting a systematic way of predicting adverse health outcomes based on accumulated mechanistic knowledge. A major challenge for broader application of the AOP concept in regulatory toxicology, however, has been developing robust AOPs to a level where they are peer reviewed and accepted. This is because the amount of work required to substantiate the modular units of a complete AOP is considerable, to the point where it can take years from start to finish. To help alleviate this bottleneck, we propose a more pragmatic approach to AOP development whereby the focus becomes on smaller blocks. First, we argue that the key event relationship (KER) should be formally recognized as the core building block of knowledge assembly within the AOP knowledge base (AOP-KB), albeit framing them within full AOPs to ensure regulatory utility. Second, we argue that KERs should be developed using systematic review approaches, but only in cases where the underlying concept does not build on what is considered canonical knowledge. In cases where knowledge is considered canonical, rigorous systematic review approaches should not be required. It is our hope that these approaches will contribute to increasing the pace at which the AOP-KB is populated with AOPs with utility for chemical safety assessors and regulators.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633887PMC
http://dx.doi.org/10.1093/toxsci/kfab113DOI Listing

Publication Analysis

Top Keywords

pragmatic approach
8
adverse outcome
8
outcome pathway
8
chemical safety
8
regulatory toxicology
8
systematic review
8
review approaches
8
considered canonical
8
knowledge
6
aop
5

Similar Publications

COVID-19 and the moral failure to protect the most vulnerable.

J Healthc Sci Humanit

January 2024

Director, Northern Plains Ethics Institute, Editor, Springer's International Library of Bioethics, Professor of Philosophy and Ethics, History, Philosophy, and Religious Studies-Dept. 2340, Minard Hall 422J, P.O Box 6050, North Dakota State University, Fargo, ND 58108, [701] 231-7038, Email: dennis.

The USA's COVID-19 pandemic experience is an example of privileged thinking that what generally works for those in power ought to be the standard for what makes medical interventions, research, treatments, and policy ethical. As a result of not focusing on doing whatever was required for vulnerable or susceptible populations or their members to achieve their health and flourishing, there are a disproportionate numbers of COVID-19 infections and deaths in Black, Hispanic, and indigenous communities. Future studies will likely show even more harm and larger health failure than known of now.

View Article and Find Full Text PDF

Background And Aims: This study aimed to describe Crohn's disease perianal fistulizing lesions in patients undergoing surgery over 60 years to compare clinical presentation, management and outcomes with those observed in younger patients.

Methods: Between January 2012 and December 2022, all patients over 60 years old who underwent a first surgical intervention for anal fistula at two medical centers were included. For each patient included, two younger patients who underwent the same surgical procedure during the same period in the same centers were matched for comparison.

View Article and Find Full Text PDF

Cell death in multiple sclerosis.

Cell Death Differ

September 2025

Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) characterized by inflammatory demyelination and progressive neurodegeneration. Although current disease-modifying therapies modulate peripheral autoimmune responses, they are insufficient to fully prevent tissue specific neuroinflammation and long-term neuronal and oligodendrocyte loss. Growing evidence implicates various regulated cell death (RCD) pathways, including apoptosis, necroptosis, pyroptosis, and ferroptosis, not only as downstream consequences of chronic inflammation, but also as active drivers of demyelination, axonal injury, and glial dysfunction in MS.

View Article and Find Full Text PDF

Associations of dietary mineral intakes with the risk of six common mental disorders: A prospective cohort study.

J Affect Disord

September 2025

NHC Key Laboratory of Environment and Endemic Diseases, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, Xi'an, Shaanxi, 710061, China. Electronic ad

Background: Evidence on the relationship between dietary minerals and mental disorders remains limited and inconsistent. This study assessed the associations between twelve essential minerals and six major mental disorders.

Methods: We included 199,877 participants from the UK biobank without implausible energy intake, missing covariates, or baseline mental disorders.

View Article and Find Full Text PDF

Head and neck squamous cell carcinoma (HNSCC) represents a significant public health burden in developing countries, where access to early diagnosis, comprehensive care, and research infrastructure is limited. This article synthesizes the insights generated during a Fireside Chat convened by members of the Latin American Cooperative Oncology Group (LACOG)-Head and Neck and the Brazilian Group of Head and Neck Cancer (GBCP), with the participation of international expert Professor Hisham Mehanna. The discussion addressed key challenges and opportunities in clinical and translational research within resource-constrained settings.

View Article and Find Full Text PDF